Carnegie acted as sole book-runner in the secondary placing of 2.3 million shares in Recipharm. The shares were sold by Carnegie on behalf of Pentafar (PT). November 2014
Healthcare
Secondary placing of shares in Recipharm (SE) — SEK 269 million
November 2014